NCT03418831View on ClinicalTrials.gov

Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

April 30, 2019

Study Completion Date

July 30, 2019

Conditions
Schizophrenia
Interventions
DRUG

Raloxifene Hydrochloride

60 mg per capsule (1 tablet daily) for 12 weeks

OTHER

Placebo

1 tablet daily for 12 weeks

Trial Locations (1)

201108

CHINA, Shanghai

All Listed Sponsors
lead

Shanghai Mental Health Center

OTHER

NCT03418831 - Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women | Biotech Hunter | Biotech Hunter